A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada
Our multidisciplinary model of care increased the proportion of HCV RNA+ people released from prison who subsequently achieved SVR, at an additional cost of C$25,653 per additional patient. This is only C$5,653 more than the estimated cost of direct-acting antivirals, providing an economic rationale for broader implementation.
Authors
- Alexandros Halavrezos
- Bertrand Lebouché (ORCID: https://orcid.org/0000-0002-1273-9393)
- Sylvie Chalifoux
- Camille Dussault (ORCID: https://orcid.org/0000-0002-3555-9766)
- Éric Latimer (ORCID: https://orcid.org/0000-0002-4485-1056)
- Lina Del Balso
- Nadine Kronfli (ORCID: https://orcid.org/0000-0003-2724-0496)
- Joseph Cox (ORCID: https://orcid.org/0000-0002-7041-1556)
- Andrea Mambro
- Giada Sebastiani (ORCID: https://orcid.org/0000-0003-2655-8283)
- Apostolia Petropoulos
- Mona Lim
- Charlene Weight
- Marina B. Klein
Institutions
- Douglas Mental Health University Institute (CA)
- McGill University Health Centre (CA)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1016/j.drugpo.2025.105136
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 23.38